Galectin Therapeutics (GALT) Share-based Compensation Growth (1y) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 206.26% |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -69.95% |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 0.18% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 0.66% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 23.70% |
| 10 | Galectin Therapeutics | 165.77 Mn | 151.67 Mn | - | 46.58% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 46.58% |
| Dec 31, 2025 | -82.35% |
| Sep 30, 2025 | -3.30% |
| Jun 30, 2025 | -32.25% |
| Mar 31, 2025 | -22.52% |
| Dec 31, 2024 | 172.84% |
| Sep 30, 2024 | -12.12% |
| Jun 30, 2024 | 43.02% |
| Mar 31, 2024 | -8.76% |
| Dec 31, 2023 | -40.53% |
| Sep 30, 2023 | -13.95% |
| Jun 30, 2023 | -20.25% |
| Mar 31, 2023 | -22.84% |
| Dec 31, 2022 | 4.13% |
| Sep 30, 2022 | 16.01% |
| Jun 30, 2022 | 11.36% |
| Mar 31, 2022 | 2,351.43% |
| Dec 31, 2021 | 15.34% |
| Sep 30, 2021 | 43.87% |
| Jun 30, 2021 | 47.46% |
| Mar 31, 2021 | -91.86% |
| Dec 31, 2020 | 36.96% |
| Sep 30, 2020 | -1.45% |
| Jun 30, 2020 | -11.06% |
| Mar 31, 2020 | 4.37% |
| Dec 31, 2019 | -90.66% |
| Sep 30, 2019 | 41,300.00% |
| Jun 30, 2019 | -69.30% |
| Mar 31, 2019 | 5,785.71% |
| Dec 31, 2018 | 73,800.00% |
| Sep 30, 2018 | -99.57% |
| Jun 30, 2018 | 436.43% |
| Mar 31, 2018 | -50.00% |
| Dec 31, 2017 | -98.74% |
| Sep 30, 2017 | -38.83% |
| Jun 30, 2017 | -33.08% |
| Mar 31, 2017 | -98.86% |
| Dec 31, 2016 | 573.24% |
| Sep 30, 2016 | -52.59% |
| Jun 30, 2016 | -49.75% |
| Mar 31, 2016 | 30.80% |
| Dec 31, 2015 | -91.11% |
| Sep 30, 2015 | -9.58% |
| Jun 30, 2015 | 7.38% |
| Mar 31, 2015 | 3,640.00% |
| Dec 31, 2014 | 55.75% |
| Sep 30, 2014 | -51.49% |
| Jun 30, 2014 | 330.64% |
| Mar 31, 2014 | -97.07% |
| Dec 31, 2013 | -17.52% |
| Sep 30, 2013 | 120.76% |
| Jun 30, 2013 | -80.32% |
| Mar 31, 2013 | 80.13% |
| Dec 31, 2012 | 124.13% |
| Sep 30, 2012 | 26.19% |
| Jun 30, 2012 | -33.81% |
| Mar 31, 2012 | -33.47% |
| Dec 31, 2011 | -78.90% |
| Sep 30, 2011 | 60.64% |